Relationship between BrainAge Polygenetic Risk Score and plasma biomarkers in the A4/LEARN studies

  1. Jorge Garcia Condado
  2. Mabel Seto
  3. Madison Cuppels
  4. Colin Birkenbihl
  5. Hannah M. Klinger
  6. Gillian T Coughlan
  7. Michael J Properzi
  8. Hyun-Sik Yang
  9. Aaron P Schultz
  10. Jasmeer Chhatwal
  11. Dorene M Rentz
  12. Asier Erramuzpe
  13. Jesus M Cortes
  14. Keith A Johnson
  15. Reisa A Sperling
  16. Rachel F Buckley
  17. Ibai Diez
0 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Background and Objectives

To examine the association between genetic predisposition to accelerated brain aging—measured with polygenic risk scores (PRS) derived from BrainAge models—and plasma biomarkers of Alzheimer’s disease (AD), with attention to age and sex-specific effects.

Methods

We analyzed 1994 cognitively unimpaired participants from the A4/LEARN studies (71.5±4.8 years; 41% male). We computed the genetic risk of accelerated grey matter loss associated with age using GWAS data from previous studies. Baseline plasma biomarkers included pTau217 (N=980; Eli Lilly immunoassay), and GFAP and NfL (N=1636; Roche Elecsys immunoassay). General linear models tested associations between each PRS and each biomarker, including PRS-by-age interaction terms. Analyses were additionally stratified by sex.

Results

BrainAge PRS moderated the association between age and pTau217 levels (β=0.08±0.03, p=0.0086), such that higher PRS for BrainAge was associated with increased pTau217 at older ages. Results were robust to covariates. This association was significant in females but not in males. No significant associations were found with GFAP or NfL.

Discussion

Genetic risk for accelerated grey matter loss with aging is associated with elevated pTau217 levels in cognitively unimpaired older females. These findings suggest a sex- and age-specific genetic link between brain aging and early AD pathology.

Related articles

Related articles are currently not available for this article.